Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Treace Medical Concepts Inc (TMCI)

Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 372,048
  • Shares Outstanding, K 62,008
  • Annual Sales, $ 187,120 K
  • Annual Income, $ -49,530 K
  • 60-Month Beta 0.18
  • Price/Sales 2.01
  • Price/Cash Flow N/A
  • Price/Book 2.97
Trade TMCI with:

Options Overview Details

View History
  • Implied Volatility 100.69% ( -80.30%)
  • Historical Volatility 297.66%
  • IV Percentile 85%
  • IV Rank 47.61%
  • IV High 180.99% on 06/13/24
  • IV Low 27.73% on 06/20/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 45
  • Volume Avg (30-Day) 771
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 18,325
  • Open Int (30-Day) 16,139

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.28
  • Number of Estimates 4
  • High Estimate -0.26
  • Low Estimate -0.31
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.86 +23.25%
on 05/21/24
6.45 -7.07%
on 06/12/24
+0.99 (+19.80%)
since 05/14/24
3-Month
3.92 +52.81%
on 05/08/24
13.24 -54.76%
on 04/01/24
-6.21 (-50.90%)
since 03/14/24
52-Week
3.92 +52.81%
on 05/08/24
26.06 -77.01%
on 06/15/23
-19.63 (-76.62%)
since 06/14/23

Most Recent Stories

More News
TREACE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 5.98 (-0.33%)
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 0% and 6.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

TMCI : 5.98 (-0.33%)
RWLK : 1.0501 (+6.07%)
TREACE SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 5.98 (-0.33%)
TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 5.98 (-0.33%)
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates

PROCEPT BioRobotics Corporation (PRCT) delivered earnings and revenue surprises of -6.78% and 1.28%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

PRCT : 62.66 (-1.29%)
TMCI : 5.98 (-0.33%)
TREACE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 5.98 (-0.33%)
TREACE SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 5.98 (-0.33%)
Treace Medical Concepts (TMCI) Surges 7.6%: Is This an Indication of Further Gains?

Treace Medical Concepts (TMCI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the...

TMCI : 5.98 (-0.33%)
ITGR : 115.84 (-0.76%)
TREACE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 5.98 (-0.33%)
TREACE SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace"...

TMCI : 5.98 (-0.33%)

Business Summary

Treace Medical Concepts Inc. is a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus. Treace Medical Concepts Inc. is based in PONTE VEDRA, Fla.

See More

Key Turning Points

3rd Resistance Point 6.31
2nd Resistance Point 6.21
1st Resistance Point 6.11
Last Price 5.98
1st Support Level 5.91
2nd Support Level 5.81
3rd Support Level 5.71

See More

52-Week High 26.06
Fibonacci 61.8% 17.60
Fibonacci 50% 14.99
Fibonacci 38.2% 12.38
Last Price 5.98
52-Week Low 3.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar